Reddit Posts
MDAI - “We are pleased to reach this milestone towards the initial commercialization opportunity for our DeepView AI®-Burn algorithm."
MDAI - announced the submission of an application in the United Kingdom for its predictive software DeepView AI®-Burn to be registered as UK Conformity Assessed (UKCA) for burn wound use in the UK.
MDAI - The DeepView® Wound Imaging System
MDAI nice day to accumulate with FDA pending news
MDAI nice day to accumulate with FDA pending news FDA
MDAI nice opportunity to load up today
MDAI nice week ahead...enjoy the ride
MDAI in the last post I forgot to post CTB situation
MDAI has only 240k float with 50% SI and CTB around 300%
MDAI...These things don't happen often..240k float with 50% SI and CTB around 300%.
MDAI...These things don't happen often..240k float with 50% SI and CTB around 300%..
NEGG lot of spamming posts by shorters...hope you took your profits. If you are looking for a nice squeeze MDAI is one of the best. The new hype is here.
Did you load up some MDAI in the last days...?
MDAI where could go with the squeeze and the news incoming?
MDAI very tiny float..high SI.. CTB around 300% and news incoming
MDAI accumulation is ending..nice squeeze incoming
Hope you loaded up enough MDAI 2 days ago... squeeze incoming
MDAI very tiny float ..high SI and CTB around 300%
MDAI could pop hard today with tiny float
Penny stocks to watch now? 4 turning heads this week
$MDAI micro float with +$100M in contracts
Mentions
I read “check cash” quickly today when glancing at $MDAI & thought “that makes sense” with the shape of the economy… Now if someone can find me an *actual* check-cashing penny stock I’ll pay you.
MDAI i’m buying every chance i get
MDAI, just in time for the hopeful FDA approval. I reccomend you checking it out!
MDAI, maybe FDA approval i getting closer🤞🏻
$MDAI is having an unusual strong and steady momentum buying day on no explicit news. Since FDA decision is anticipated by the end of Q2, this is feeling like someone knows something…
$MDAI is about to be first mover to the AI diagnostic triaging market with FDA approval of their DeepView system by June this year which will determine on Day 1 of injury where surgical intervention is necessary (compared to Day 21, the current standard of care). They forecast $24,000 average savings per hospitalized burn patient, of which there are 40,000 in the US alone. This represents ~$1B of yearly savings just for US hospitalized burn patients, not accounting for the rest of the 500,000 Americans that visit hospitals for burns every year. If Spectral AI captures just some of that as revenue, they’ll be huge. They just got extended $31 million in BARDA funding for commercialization in anticipation of the FDA decision, all that’s left is for the FDA to say yes.
MDAI steadily building in recent days
Is it me or is the premarket pretty dead ? Maybe orange man should same something so it would move something :D PS! Only in MDAI.
I'm coming to terms with the fact I've been scammed and that I won't get my £12k back. So do I pull my remaining 10k out on Monday, thinking of just dumping it all in MDAI. Been watching it for the last 6 months.
I am in MDAI. Been holding for few days. Seems to be going up slowly 🐌. They've got post market earnings on 24th. If good news, will go even higher.
Up next, MDAI. Chart is looking great and volume is way up
CYCU Current price around $1.21 (down ~2.42% recently), with normal/low volume and a tiny market cap of ~$5M. No major recent news or catalysts on the page—appears quiet with no clear driver for movement beyond general market or low-float volatility typical for micro-caps. DVLT Current price around $0.80 (down ~14.3% on heavy volume of 113M+ shares vs. avg ~72M), market cap ~$463M. What's moving it: Recent Q4 2025 earnings showed the first profitable quarter, record revenue growth, and a reiterated $200M revenue target for 2026 (~400% YoY growth). It also announced a definitive agreement to acquire NYIAX (AI-driven data monetization + institutional infrastructure) MDAI Current price around $1.42 (up +18.33% with massive volume spike of ~7M shares vs. avg ~414K), market cap ~$43.6M. What's moving it: Strong catalyst from a $31.7M BARDA (U.S. government) funding award to accelerate DeepView System development. Other notes include upcoming Q4 2025 earnings, a new CEO appointment, and participation in National Burn Awareness Week. The funding news is clearly driving the surge and volume. CJMB NOTHING MUCH HERE … group chat driven stock discord , Reddit . I stand Corrected here PROP (Prairie Operating Co.) Current price around $1.57–$1.63 (modest +1–2% moves recently), market cap ~$90–118M. What's moving it: No major breaking news today, but upcoming catalysts include senior management attending the ROTH Conference (March 22–24, 2026) and Q4/full-year 2025 financial results release (after close on March 31, 2026). Moves appear tied to broader energy sector sentiment, conference anticipation, or low-float trading rather than a specific event. OPTT Current price around $0.36 (small +1.7% or volatile moves), market cap ~$82M. Recent quarterly revenue was down (to ~$513K) with ongoing losses. What's moving it: Recent volatility includes reports of the stock more than doubling after a "leading" energy company commissioned a feasibility study (specific catalyst for a prior surge). Broader moves stem from its penny-stock nature, marine/energy sector news, or contract potential, despite weak recent earnings. Volume can spike on any development.
Yes it's helpful when you're interested. But I keep finding things that I didn't even know existed. Electric bike companies LFEV and AI burn equipment MDAI and a miracle material HGRAF. Even this company that's suing Samsung and Micron for copywrite infringement and winning. If they win in International Trade Court they will get billions more in damages or probably bought out. Which would be huge gains. The stock is 1.50 right now NLST. Safest 10X is ASTS, also. Check out Serenity on X. He's knowledgeable on the upcoming supercycle photonics This guy is doing TWO 10k to million challenges. You can see his history and what he's invested in now. Invest along with a millionaire! h [ttps://doublebubbler.com/trading-history/](https://doublebubbler.com/trading-history/) Also RetiredPortfolioMgr is a very cool guy on here. He has eyesight problems and is an enthusiastic typer but don't be fooled! Good luck, bro, keep us updated!
MDAI had some goverment funding, think it shows support
why is $MDAI dropping so much even with good news?
MDAI moving in pre market after 31.7 mil BARDA funding news
totally get what you're saying... that funding is a big deal, especially since it's non-dilutive. MDAI dropping to $1.20 today after that news feels weird. like, are people just not seeing the potential here? if the FDA decision drops soon, this could really blow up. honestly, the risk/reward seems pretty solid at this price. but with the market being so unpredictable, you never know how it'll react. earnings call on the 24th is gonna be crucial, and it'll be interesting to see if they give a hint about FDA status. fingers crossed!
DVLT dumping and MDAI also dropping but both could be coming back if volume picks up
Sorry guys. Bought into MDAI and it went down.
Anyone trading MDAI today? They’ve got huge news and already a lot of action in AH.
Premarket Watchlist **$LBGJ** : Round two? **$ENSC** : Micro Bio **$ORIS** : Needs volume :flag_cn: **$CMCT** : Continuation if volume **$IOBT** : 3/30 Earnings ( @mamegan. ) **$MDAI** : https://finviz.com/news/338447/spectral-ai-awarded-317-million-of-barda-funding-to-accelerate-development-of-the-deepview-system
MDAI is having a go after market.
I have a fear with RCKT bc my friend invested in this stock last year when patient died in trials and the stock fell pretty hard after that. My friend stills hold the stock though waiting for the pump up in price. I feel that I have overextended my portfolio with biotech related stuff (DRTS, IMRX, MBOT, MDAI). Yesterday I added 100 shares to DRTS, DDD, NB, CTM, PDYN, MBOT and Kopin (Ondas and UMAC bought Kopin shares with 2.10 price last September for long-term potential, my average is 2.22 and sitting with 300+ shares, earnings coming up in a week or two) I also bought 200 shares of Canadian Uranium mining company Denison Mines which is under 4$ right now, should be a good entry price but there seems to be a dilution fear with it right now)
Had to repost this without the subreddit links Not saying they can't drop 30% in a week... but RDZN is my favorite pick for 2026. They are in a nice accumulation zone after a pullback. Maybe goes lower. I am planning to compile a large DD this weekend and will post it on RDZNai sub. They are at a profitability inflection with breakeven/profit expected at next earnings (May/June). Currently at $1.15 and I'm aiming for $5 in 2027. AMPX is still a buy but its at ATH right now so buy the dips. MDAI has a highly probable FDA approval expected in 2-3 months for a burn scanning device. Right now is a great entry point. SLS has massive potential for 5x - 50x (depending who you ask) this year/next year on their cancer drug trial readout. Buying now at $5 is fine, hold and wait for trial completion. HGRAF - if you ask HGRAF believers they think HydroGraph will conquer the world with fractal graphene and the price target is immeasurable. It's possible. They plan to uplist from OTC to Nasdaq this year which will open it up to Robinhood retailers and more institutional buyers. Buy the dips. ASTS - Huge potential to 3-5x in 2 or 3 years if they get their satellites up on the planned timeline. I'm accumulating under $100. AMSC - Their superconducting magnetic tapes are necessary in fusion reactors and they are one of like 3 who can make them. Thats for the future, but they do tons of other stuff now and are profitable + growing. Unfairly beaten down. I own all these except HGRAF which I just sold after a 4x run. Obviously do your own DD and risk manage properly. These all have potential to fail. We are in a weird market with multiple wars going on so anything can happen.
Avish, is there any update on MDAI? They submitted for FDA approval June 2025
$MDAI. 250 mil barda funding, medical device not medicine which makes it way safer in terms of approval and risk. They get answer on de novo breakthrough device anytime
Haha. There will be some cool drugs/ materials/ medical innovations from it, though. I invest in MDAI! I'm using Gemini more and more so I don't have to search all over god's creation to get simple answers.
Came to this post’s comments to make sure MDAI was in here
I'm all in on PGY and MDAI. I lost logic long time ago
Check out these for scalps: 1) SES -good momentum lately 2) DGXX expecting an announcement soon I believe 3) MDAI - in overbought territory. but keeps rising up anyway. FDA approval Feb/March to Summer 4) AUR - it keeps vacillating between minor pull backs and minor surges 5) AREC if price floor thing for critical minerals is true, maybe AREC would be okay too. All of these are long term holds for me. SES and DGXX I scalp pretty much every day. AUR every other day or two.
MDAI. Buy it and forget about it until June/July. Hopefully FDA approval. Worst case scenario you lose $75.00. Best case you win $2000. Welcome to the casino.
Yup, it’s my largest holding. And it looks like depending on when you bought MDAI, you should been in the green right now 😃
This is selling after it gets FDA approval. You can swing trade shares now attempting to get a lower and lower cost basis over time. MDAI doesn’t fluctuate very much. It’s a slow mover in either direction right now.
For MDAI I’ll probably sell anything above $1.50, so that’ll be me keeping 1,100 shares. Selling 2,400 shares. May just keep 500 shares of MDAI. Depends on what the updates are around FDA approval. For ATCH, I’ll probably sell whatever is above .60. This will leave me with around 40,000 shares. Selling point will depend on momentum and updates. Don’t cut your winners too early kind of mindset. Some holdings take months to years to pan out for good returns. Penny stock traders prefer a day or few days. But I really like long term investing. I’d like to be the person who found NVDA and held for years kind of person than someone who made a quick $1000 and missed out on tens of thousands.
Thank you for the nice analysis. Where did you get the 40 million dilution number. i am seeing 71 million as of ct 2025. And there is an expectation based on what happened in 2025 that there would be an equivalent amount of dilution in 2026. [https://stonktracker.com/stock/MDAI/dilution](https://stonktracker.com/stock/MDAI/dilution)
$98 million currently, as 26 million warrants were excercised. That still leaves about 40 million warrants that can be excercised at a minimum of $1 per warrant. So further dilution is very unlikely. Current burn rate is about 7 million per quarter, although likely to increase a bit due to new, additional, trials starting soon. And yes, I believe this is my next (and hopefully biggest) money maker after RKLB, ASTS, PBC and DRTS. Bought in recently with MDAI as well.
Good old MDAI, who’s supposed to know what that means?
DGXX, HUMA, MDAI. Major catalysts inbound for all three. Already deep in the money on DGXX.
same with MDAI...using AI for burn recognition
Just opinions, definitely do your own DD/research, but these are my plays and working theses: $AMPX - my thesis for AMPX rests on a demonstrable divergence between its forensic financial reality and its distressed market valuation as of January 2026. While the market continues to price the equity as a speculative R&D venture, the company’s Q3 2025 financials confirm a commercial inflection point characterized by 173% year-over-year revenue growth and, crucially, a shift to positive 15% gross margins—a rarity for early-stage hardware firms. This margin profile validates the unit economics of their silicon anode technology, proving that industrial customers in the aviation and defense sectors are willing to pay a premium for superior energy density. Furthermore, the implementation of a capital-efficient "Fab-Light" manufacturing strategy allows for rapid backlog conversion without the immediate need for dilutive financing, creating a favorable risk-reward profile supported by a $53 million backlog and a geopolitical tailwind favoring non-Chinese battery supply chains. $DGXX - classic deep value opportunity driven by a stark disconnect between its current market capitalization and the intrinsic value of its tangible assets. The stock is currently trading at a valuation that barely exceeds its \~$100 million liquidity position, implying that the market is assigning a near-zero enterprise value to its operating business and 196.7 MW of secured power infrastructure. This creates a significant margin of safety for investors, as the debt-free balance sheet mitigates bankruptcy risk while the company executes a capital-intensive pivot from low-multiple cryptocurrency mining to high-margin AI colocation and GPU-as-a-Service. If management successfully deploys its ARMS 200 units and monetizes the recently announced 1.3 GW capacity pipeline, the stock could undergo a violent multiple expansion, re-rating from a distressed commodity play to an AI infrastructure asset. $HUMA - dislocation between price and intrinsic value, trading at a market capitalization of roughly $182 million that fails to reflect the sunk cost and strategic utility of its FDA-approved bio-manufacturing platform. The current valuation appears to price the asset solely on the immediate, friction-heavy revenue ramp of its trauma indication ignoring the "strategic put" offered by its Department of Defense ECAT listing and the substantial option value embedded in its Phase 3-validated dialysis pipeline. With a strengthened balance sheet extending the cash runway into late 2026, the market is discounting a commercial-stage biologic to near-liquidation levels, creating a highly asymmetric risk/reward profile for people (like me) willing to look past the temporary lag of hospital procurement cycles to the broader adoption curve and pipeline expansion. $MDAI - event-driven value opportunity where the market has inefficiently priced the company's transition from clinical development to commercialization. The recent contraction in equity value, driven largely by a headline decline in R&D revenue, fundamentally misinterprets the completion of pivotal government-funded trials as operational weakness rather than a necessary precursor to the FDA decision expected in the first half of 2026. With the DeepView System demonstrating statistically significant superiority over human clinical judgment in burn assessment and a liquidity runway secured through non-dilutive BARDA contracts and debt facilities, the current valuation offers an risk-reward profile that fails to account for the company's defensive IP moat and the high probability of regulatory clearance. $POET - presents a compelling long opportunity driven by its successful pivot from a capital-constrained R&D firm to a commercial manufacturer with a fortified balance sheet. The company recently secured approximately $250 million in equity financing, effectively eliminating near-term insolvency risk and providing the liquidity necessary to scale production of its Optical Interposer platform without the overhang of immediate dilution. This capital injection aligns with a critical point in the semiconductor cycle, where data center infrastructure is hitting physical limitations with copper interconnects, necessitating a shift to optical solutions 1.6T data speeds. With validated partnerships like the 1.6T optical engine collaboration with semtech and indirect exposure to Amazon’s hardware roadmap through the Marvell/Celestial AI acquisition, POET has product-market fit in a high-growth vertical. Consequently, the stock currently reflects a valuation dislocation, trading on irrelevant trailing financials rather than its emerging earnings power and strategic position within the AI hardware supply chain. I'm also long NVDA/GOOGL/IONQ.
Hey, MDAI's FDA shot and Hirsch backing scream upside, but SPAC scars and biotech vol (delays, flops) are real risks. - DYOR on de novo timelines; watch for dilution. - Diversify to hedge—biotech bets can wipe out. - Trade-off: 250-500m exit pop vs. total bust. For stable alts, DeFi like Morpho yields 5-8% on USDC. Yieldseeker on Base auto-manages passively as an option. What's your entry price?
MDAI - FDA catalyst should be dropping some time Q2 or early Q2. AI medtech.
MDAI is the the ultimate penny stock. Catch it now before it takes off!
MDAI. FDA approval expected anytime in March or before. AI imaging tech for diabetic wounds and burns. US military wants this technology yesterday. Like many biotech or biopharm stocks, I expect there will be a pre-run up to FDA approval, FDA approval spike, and then the mass sell off afterwards. Don’t expect that if the stock spikes to $4, it won’t just fall under $2 within a week. Most spikes aren’t sustained longer than a day or two. FDA approval is not assured, timeline for approval isn’t 100% by March at the latest, and you could have the market just shrug off the news. There are always risks in biopharm and biotech. I’ve got 1700 shares right now. Just slowly adding to my position, might have 3000-5000 shares as my max buy. Riskiest bet I’m in now is ATCH. They are applying to buy a fed member bank by end of this month. Could be approved. Could not be approved. Who knows what the timeline is. Will the market shrug off the news? Even though this is a fintech stock, it behaves more like a biopharm stock. But anything with batteries, energy storage, and that sort of thing is worth looking into. Datacenters, AI, drones, solar, robots, etc all need power and more of it.
Well if you are presenting a scale of worthless to completely worthless, I'd just move on. I closed out MDAI on this scale for tax purposes lol. Sometimes, especially realizing losses in Dec, is just a move on moment. In the moment the value to my portfolio was just loss. Not saying it's bad, but it was right for me here.
I'm not very active on reddit as a poster. Hence the little amount of posts. The other stock i talked about before, MDAI, is a stock i still believe in. Just waiting for FDA approval now, so it's cooling down. Still had a good profit though. Same for Rezolve. Bought earlier at 2,50, so no bags here. Just lots of opportunity.
Spectral AI. — Ticker symbol on the NASDAQ is MDAI. With a market cap of only $45 million, this stock is extremely undervalued and can easily be a 10X or 100X bagger.
Interesting DD. One thing I’d add from the drug side (vs diagnostics): FDA risk tolerance really depends on context. Elevidys is a good example. Sarepta went through a long, messy approval path because it’s a one-time gene therapy for a fatal pediatric disease. The FDA still allowed accelerated approval with post-marketing commitments because the unmet need was huge and doing nothing also carried real risk. MDAI is very different (non-invasive, diagnostic, low patient risk), which should make the bar cleaner in some ways-but FDA scrutiny doesn’t disappear, it just shifts to validation, generalizability, and real-world performance.
I did a very modest investment on 4 micro stocks suggested from this sub that after doing my own research which I thought there was long-run speculative potential— RZEN, AMPX, MDAI and ACON. So far, not so good.
100% re: selling the runner that I have learned which has been a big part of the success this year. Achr in with loads at 8.50 then out at 11.50 was a highlight earlier this year. If DFLI rips to 3 any time soon I'll drop 50% or more and go back into my drones stocks and a couple of others. If it hits 2 I'll halve my holding. Given my long term outlook I'll all about finding 5 and 10 baggers. My other 10% right now is in ATCH (down 30% rn) which is a lottery ticket but if they execute next couple of years will do well. If DFLI rips I'll buy more of those cos I'm starting to believe they're turning the corner and are well off the radar a little like DFLI. I don't generally like pharma companies but I'm vibing (your word haha) on MDAI if they get FDA approval on their AI DeepView system I reckon that one could 10-20x next few years.
GOOG was my biggest winner this year. Sold early on AMD and ASML My next high conviction plays for first semester of 2026 are PGY and MDAI
Look into MDAI next. FDA approval 99% chance Q1 2026
Well I'm stuck with $2.5 MDAI so MDAI it is... :/
MDAI as long as it get approved by the FDA, which seems likely.
What I'm watching this week - DFLI, ASST and MDAI earnings tomorrow.
Essentially a ticket which guarantees you a stock at a certain price. If you have warrants at $2, but MDAI shares are now $10. You can exercise your warrants and buy stock at $2. They do also have an expiry date so slightly riskier than buying stock
MDAI continuing to base well ahead of FDA approval and potential strategic acquisition after that
Does MDAI have a potential FDA approval date?
MDAI - just got thru raising growth capital. Clear path to fda approval and already funded by the Defense Dept. TROX - just look at the all time chart. Nice yield, cyclical low, rare earth upside.
MDAI Spectral AI looks good. Coming month can be big with the FDA approval
Thanks! I like it. Check out MDAI. They have fda approval coming up for their device. It is an easy sell to hospitals , govt. Etc. And this is where AI is very useful right now. It will save hospitals money.
I think the problem is deeper than that and using Reddit as your sole intuition on stocks will make you lag most of the time. Bynd was a nice grab here recently but overall I’m learning that Reddit mostly fails to deliver (CCCX, USAR, MDAI) and instead I’m leaning back into my own intuition. For example I think water is becoming scarce. So I’m investing in water purification companies. Or I believe in climate change, so I’m buying ac and heating stocks, lastly I want companies that are profiting year after year.
All these pump/dump is risky business! $MDAI looks solid mid-long term. Still not a bad entry point. Government contracts, FDA approval most likely and you can potentially double your money in just a few months.
MDAI holding up nicely despite the growth capital raise. Now full steam ahead to fda approval and commercialization
TMC, ADUR, BEEM, MDAI, and REKR. I’m also starting to scale into a position in SNCR. These are all in my small speculative portfolio, most of my money is either in a pension or passive funds. If you’ve got any questions about my picks, I’d be happy to answer them!
Keeping a close eye on DFLI, MDAI, NUAI the next few days
I never went to this sub before, but randomly went in too check, saw the DD on BYND and I thought it was solid enough and meme-y enough. Of course you can always buy more and there are things to regret but I managed to buy at 0.6 and some calls at 0.8. The next thing I'm looking at is $MDAI, but I mainly don't know what I'm doing.
Not for MDAI - grinding higher day by day
Never enter a stock thats already gone, its like try to enter a moving car. And dont have the mentality of ”nerd to make my money back” that will make you desperate enough to enter a new bad trade and trigger à downfall spiral. Thats doesnt mean that there isnt good stocks being recommended here and that you shouldn’t try to make your losses back but try to be smart about it. Check my latest post about MDAI, this is the kind of trades i make, i lower the risk by chosing strong stocks fundamentally that actually have legs to stand on snd then pick the right window to buy and hold. Read the post and you will get and idea of how i do it. That said, it doesnt make it bulletproof but atleast lowers the risk to a level where it makes it more rewarding than stressful. Good Luck 🫡
$MDAI showing a lot of strength today, feels like new positions are getting added and a floor is forming around $2.50. Warrants showed unusually high volume (6x average) and a 30% intraday spike. We may see upper $3 later this week/next week. This stock blows up a 50% run on a positive FDA update if I had to guess.
Great overview! I’ve been believing in this value play since mid-2024 and my portfolio is 2/3rds just this micro cap. The fundamental technology has been nothing but good news, filling a diagnostic niche for burns but also will expand to diabetic foot ulcers and I’m sure a range of other wound types. FDA approval will confirm the viability of this technology for burn and likely other indications and will make MDAI a juicy buyout target, especially with $95 million of BARDA funding getting unlocked upon approval.
Im buying MDAI Monday it’s on discount
MDAI a better bet but hope these vegan burger mofos get their bread lol
MDAI is a pump dump stock. It’s had 2 major pumps in the past 5yrs but is has also had a MASSIVE decline since its original stock price. That stock is bears and bulls playing games with each other. Sure- potential for a 2x but not reliable and you can never predict which way it’s going to go since it relies on temporary hype